Epilepsy Drugs Market 2028 By Treatment, Distribution Channel and Geography | The Insight Partners

report image

Epilepsy Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Treatment (First Generation Anti-epileptics, Second Generation Anti-epileptics, Third Generation Anti-epileptics); Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Others) and Geography

Report Code: TIPRE00024323 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Epilepsy is a chronic central nervous system disorder (neurological disorder). It is characterized by abnormal brain activity that results in sudden and recurrent seizures or periods of unusual behavior and sensations. It affects people of all ages, and the majority of the cases have no identifiable cause. The epilepsy drugs help in the treatment of seizures (symptomatic treatment), although there is no cure for epilepsy.


The "Global Epilepsy Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the epilepsy drugs market with detailed market segmentation by treatment, distribution channel and geography. The report provides key statistics on the market status of the leading epilepsy drugs market players and offers key trends and opportunities in the market.


  •  Based on treatment, the global epilepsy drugs market is segmented into first generation anti-epileptics, second generation anti-epileptics and third generation anti-epileptics.
  •  Based on distribution channel, the market is segmented into hospital pharmacy, pharmacy stores and others.


  •  Increase in the incidences of epilepsy, neurological disorders, and birth-related injuries.
  •  The rise in the new drug approvals.
  •  Growing awareness regarding epilepsy disease.
  •  Increase in the investment for R&D activities.


  •  High cost of patented drugs.
  •  Low accessibility to epilepsy drugs in low and middle-income economies.
  •  Certain side effects associated with the drugs.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The epilepsy drugs market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the epilepsy drugs market in these regions.


COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The coronavirus outbreak caused a worldwide economic crisis. All the industrial manufacturing operations were halted due to the restrictive measures, lockdown, and business shutdown. The disruptions in the regular operation of business caused a significant impact on the epilepsy drugs market growth. The shutdown of various plants and factories affected the worldwide supply chains and negatively impacted the market's manufacturing, delivery schedules, and products sale. However, the market is expected to witness growth in demand in the future.

Get more information on this report :


The report covers key developments in the epilepsy drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from epilepsy drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for epilepsy drugs in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the epilepsy drugs market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Pfizer, Inc.
  •  Novartis AG
  •  Abbott Laboratories
  •  Sanofi S.A.
  •  UCB S.A.
  •  GlaxoSmithKline plc
  •  Sunovion Pharmaceuticals Inc.
  •  Teva Pharmaceutical Industries Ltd.
  •  Takeda Pharmaceutical
  •  Eisai Co., Ltd
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Pfizer, Inc.
2. Novartis AG
3. Abbott Laboratories
4. Sanofi S.A.
5. UCB S.A.
6. GlaxoSmithKline plc
7. Sunovion Pharmaceuticals Inc.
8. Teva Pharmaceutical Industries Ltd.
9. Takeda Pharmaceutical
10. Eisai Co., Ltd
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount